Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Fabiano

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
BMJ Case Reports|March 7, 2024
Chronic high-dose dimenhydrinate use contributing to early multifactorial cognitive impairmentNicholas Fabiano, Saumil Dholakia, Lisa A S Walker, et al.
Molecular Psychiatry|February 19, 2026
Exercise mimetics as unexplored therapeutics for treating depressionNicholas Fabiano, Jess G Fiedorowicz, Aymeric Ravel-Chapuis, et al.
Brain Health : Lifelong Brain Resilience and Longevity|June 3, 2026
The human microplastic burden and brain health: From measurement to pathophysiology and removalJulio Licinio, Charlotte Steenblock, Nicholas Fabiano, et al.
Journal of Psychiatry & Neuroscience : JPN|July 3, 2025
Switching to a muscarinic agonist to alleviate antipsychotic-induced metabolic and neuromotor adverse effects in a person living with schizophreniaNicholas Fabiano, Carl Zhou, Stanley Wong, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 17, 2025
On the potential of xanomeline-trospium chloride for schizophrenia and beyondNicholas Fabiano, Stanley Wong, Carl Zhou, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 26, 2024
Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysisNicholas Fabiano, Stanley Wong, Carl Zhou, et al.
Journal of Physical Activity & Health|December 30, 2025
Physical Activity for Autistic Children and Adolescents: Key Considerations to Support Participation and Future DirectionsPatrick Jachyra, Tine Van Damme, Sean Healy, et al.
Molecular Psychiatry|December 9, 2025
Deliberate self-harm and suicide in individuals with cannabis-related hospital contacts in Ontario, CanadaNicholas Fabiano, Emi Vargatoth, Michael Pugliese, et al.
Respiratory Medicine|October 20, 2023
Influence of pulmonary rehabilitation on symptoms of anxiety and depression in interstitial lung disease: A systematic review of randomized controlled trialsBrandon Luu, Arnav Gupta, Nicholas Fabiano, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 9, 2025
Systematic Review: Mental Health Outcomes in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating PolyneuropathyCathy Meng Fei Li, Stanley Wong, Nicholas Fabiano, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
BMJ Case Reports|March 7, 2024
Chronic high-dose dimenhydrinate use contributing to early multifactorial cognitive impairmentNicholas Fabiano, Saumil Dholakia, Lisa A S Walker, et al.
Molecular Psychiatry|February 19, 2026
Exercise mimetics as unexplored therapeutics for treating depressionNicholas Fabiano, Jess G Fiedorowicz, Aymeric Ravel-Chapuis, et al.
Brain Health : Lifelong Brain Resilience and Longevity|June 3, 2026
The human microplastic burden and brain health: From measurement to pathophysiology and removalJulio Licinio, Charlotte Steenblock, Nicholas Fabiano, et al.
Journal of Psychiatry & Neuroscience : JPN|July 3, 2025
Switching to a muscarinic agonist to alleviate antipsychotic-induced metabolic and neuromotor adverse effects in a person living with schizophreniaNicholas Fabiano, Carl Zhou, Stanley Wong, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 17, 2025
On the potential of xanomeline-trospium chloride for schizophrenia and beyondNicholas Fabiano, Stanley Wong, Carl Zhou, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 26, 2024
Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysisNicholas Fabiano, Stanley Wong, Carl Zhou, et al.
Journal of Physical Activity & Health|December 30, 2025
Physical Activity for Autistic Children and Adolescents: Key Considerations to Support Participation and Future DirectionsPatrick Jachyra, Tine Van Damme, Sean Healy, et al.
Molecular Psychiatry|December 9, 2025
Deliberate self-harm and suicide in individuals with cannabis-related hospital contacts in Ontario, CanadaNicholas Fabiano, Emi Vargatoth, Michael Pugliese, et al.
Respiratory Medicine|October 20, 2023
Influence of pulmonary rehabilitation on symptoms of anxiety and depression in interstitial lung disease: A systematic review of randomized controlled trialsBrandon Luu, Arnav Gupta, Nicholas Fabiano, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|June 9, 2025
Systematic Review: Mental Health Outcomes in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating PolyneuropathyCathy Meng Fei Li, Stanley Wong, Nicholas Fabiano, et al.
Pageof 7